146794-84-5

146794-84-5 structure

Name: Y-29794 oxalate
Chemical Name: (2-{[8-(Dimethylamino)octyl]sulfanyl}-6-isopropyl-3-pyridinyl)(2-thienyl)methanone ethanedioate (1:1)
CAS Number: 146794-84-5
Molecular Formula: C₂₅H₃₆N₂O₅S₂
Molecular Weight: 508.69
Catalog: Research Areas Cancer
Create Date: 2018-06-19 23:55:53
Modify Date: 2024-01-27 18:17:06
Y-29794 oxalate is a selective, orally active and blood-brain barrier permeable non-peptide prolyl endopeptidase inhibitor. Y-29794 oxalate blocks the IRS1-AKT-mTORC1 pathway and inhibits tumor growth. Y-29794 oxalate is also effective in inhibiting the progression of Aβ-like deposition in the hippocampus of aging-accelerated mice (SAM)[1][2][3].

Name	(2-{[8-(Dimethylamino)octyl]sulfanyl}-6-isopropyl-3-pyridinyl)(2-thienyl)methanone ethanedioate (1:1)
Synonyms	(2-{[8-(Dimethylamino)octyl]sulfanyl}-6-isopropyl-3-pyridinyl)(2-thienyl)methanone ethanedioate (1:1) Methanone, [2-[[8-(dimethylamino)octyl]thio]-6-(1-methylethyl)-3-pyridinyl]-2-thienyl-, ethanedioate (1:1) (2-{[8-(Dimethylamino)octyl]sulfanyl}-6-isopropylpyridin-3-yl)(2-thienyl)methanone ethanedioate (1:1)

Description	Y-29794 oxalate is a selective, orally active and blood-brain barrier permeable non-peptide prolyl endopeptidase inhibitor. Y-29794 oxalate blocks the IRS1-AKT-mTORC1 pathway and inhibits tumor growth. Y-29794 oxalate is also effective in inhibiting the progression of Aβ-like deposition in the hippocampus of aging-accelerated mice (SAM)[1][2][3].
Related Catalog	Research Areas >> Cancer
References	[1]. Perez RE, et al. Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer. Cancer Biol Ther. 2020 Nov 1;21(11):1033-1040. [2]. Kato A, et al. Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse. J Pharmacol Exp Ther. 1997 Oct;283(1):328-35. [3]. Nakajima T, et al. Y-29794--a non-peptide prolyl endopeptidase inhibitor that can penetrate into the brain. Neurosci Lett. 1992 Jul 20;141(2):156-60.